Financhill
Back

Appili Therapeutics Vs. Acasti Pharma Industry Stock Comparison

Sell
34

APLIF
Appili Therapeutics

Last Price:
0.03
Seasonality Move:
5.24%
Sell
50

ACST
Acasti Pharma

Last Price:
2.72
Seasonality Move:
6.78%
Sell
34
Appili Therapeutics (APLIF) is a Sell

Is Appili Therapeutics a Buy, Sell or Hold?

  • The current Appili Therapeutics [APLIF] share price is $0.03. The Score for APLIF is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • APLIF is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
50
Acasti Pharma (ACST) is a Sell

Is Acasti Pharma a Buy, Sell or Hold?

  • The current Acasti Pharma [ACST] share price is $2.72. The Score for ACST is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • ACST is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

APLIF Stock Price Chart

What is Appili Therapeutics's stock price today?

  • The Appili Therapeutics share price today is $0.03
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and APLIF is experiencing slight buying pressure.

ACST Stock Price Chart

What is Acasti Pharma's stock price today?

  • The Acasti Pharma share price today is $2.72
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ACST is experiencing buying pressure, which is a positive indicator for future bullish movement.

APLIF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0 Sell
Relative Strength Index (14 RSI): 47.45 Sell
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.03 - 0.03) Sell
Bollinger Bands (100): (0.02 - 0.02) Buy

ACST Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.1 Sell
Relative Strength Index (14 RSI): 40.83 Sell
Chaikin Money Flow: 6762 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.71 - 2.91) Sell
Bollinger Bands (100): (2.58 - 3.36) Sell

APLIF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.03 Sell
20-day SMA: 0.03 Sell
50-day SMA: 0.03 Sell
200-day SMA: 0.03 Sell
8-day EMA: 0.03 Sell
20-day EMA: 0.03 Sell
50-day EMA: 0.03 Sell
200-day EMA: 0.03 Sell

ACST Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.71 Buy
20-day SMA: 2.78 Sell
50-day SMA: 3.08 Sell
200-day SMA: 2.63 Buy
8-day EMA: 2.72 Buy
20-day EMA: 2.8 Sell
50-day EMA: 2.94 Sell
200-day EMA: 2.9 Sell

Appili Therapeutics Earnings Growth & APLIF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Acasti Pharma Earnings Growth & ACST Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.08 per share, an increase next quarter of $0.07 per share, an increase this year of $1.16 per share, and an increase next year of $0.34 per share.

Appili Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Acasti Pharma Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):